Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1970 5
1971 1
1972 5
1973 1
1974 1
1975 4
1976 8
1977 4
1978 3
1979 4
1980 4
1981 2
1982 4
1983 3
1984 4
1985 3
1986 3
1987 3
1989 2
1990 3
1991 1
1992 4
1993 5
1994 3
1995 7
1996 3
1997 6
1998 4
1999 6
2001 3
2002 8
2003 8
2004 7
2005 8
2006 10
2007 9
2008 15
2009 9
2010 21
2011 20
2012 10
2013 9
2014 9
2015 11
2016 16
2017 16
2018 14
2019 9
2020 17
2021 15
2022 19
2023 2
Text availability
Article attribute
Article type
Publication date

Search Results

339 results
Results by year
Filters applied: . Clear all
Page 1
Hypouricemia and Urate Transporters.
Otani N, Ouchi M, Misawa K, Hisatome I, Anzai N. Otani N, et al. Among authors: anzai n. Biomedicines. 2022 Mar 11;10(3):652. doi: 10.3390/biomedicines10030652. Biomedicines. 2022. PMID: 35327453 Free PMC article. Review.
Bortezomib-cyclophosphamide-dexamethasone induction/consolidation and bortezomib maintenance for transplant-eligible newly diagnosed multiple myeloma: phase 2 multicenter trial.
Muranushi H, Kanda J, Kobayashi M, Maeda T, Kitano T, Tsuji M, Ueda Y, Ishikawa T, Nohgawa M, Watanabe M, Imada K, Moriguchi T, Itoh M, Ohno H, Yonezawa A, Hirata H, Arima N, Asagoe K, Anzai N, Nagata K, Yasuno S, Kuwabara Y, Kitao H, Kim I, Kawagishi K, Ueshima K, Tominari S, Nakayama T, Yamashita K, Takaori-Kondo A. Muranushi H, et al. Among authors: anzai n. Hematology. 2022 Dec;27(1):239-248. doi: 10.1080/16078454.2022.2032915. Hematology. 2022. PMID: 35152852 Clinical Trial.
Catalytic asymmetric synthesis of α-methyl-p-boronophenylalanine.
Harada S, Kajihara R, Muramoto R, Jutabha P, Anzai N, Nemoto T. Harada S, et al. Among authors: anzai n. Bioorg Med Chem Lett. 2018 Jun 1;28(10):1915-1918. doi: 10.1016/j.bmcl.2018.03.075. Epub 2018 Mar 28. Bioorg Med Chem Lett. 2018. PMID: 29655983
Hematological diseases and apoptosis.
Tohyama K, Kawabata H, Anzai N, Hishita T, Dodo M, Yoshida Y. Tohyama K, et al. Among authors: anzai n. Intern Med. 1998 Feb;37(2):188-90. doi: 10.2169/internalmedicine.37.188. Intern Med. 1998. PMID: 9550604 Free article. Review. No abstract available.
Recent approaches to gout drug discovery: an update.
Otani N, Ouchi M, Kudo H, Tsuruoka S, Hisatome I, Anzai N. Otani N, et al. Among authors: anzai n. Expert Opin Drug Discov. 2020 Aug;15(8):943-954. doi: 10.1080/17460441.2020.1755251. Epub 2020 Apr 24. Expert Opin Drug Discov. 2020. PMID: 32329387 Review.
Urate transporters: an evolving field.
Anzai N, Endou H. Anzai N, et al. Semin Nephrol. 2011 Sep;31(5):400-9. doi: 10.1016/j.semnephrol.2011.08.003. Semin Nephrol. 2011. PMID: 22000646 Review.
Fluvastatin is effective against thymic carcinoma.
Hayashi K, Nakazato Y, Morito N, Sagi M, Fujita T, Anzai N, Chida M. Hayashi K, et al. Among authors: anzai n. Life Sci. 2020 Jan 1;240:117110. doi: 10.1016/j.lfs.2019.117110. Epub 2019 Nov 28. Life Sci. 2020. PMID: 31786191
339 results